Pulse Biosciences announced the enrollment of 100 patients across three U.S. sites in the PRECISE-BTN clinical study evaluating its nPulse Percutaneous Electrode System, with first patient visitation marking milestone progress in the development of novel bioelectric medicine for thyroid nodules.